Evidence map›Paper›PMID 28143472›Full record

ArticleBMC complementary and alternative medicine2017

Anti-inflammatory potential of Capparis spinosa L. in vivo in mice through inhibition of cell infiltration and cytokine gene expression.

Khadija El Azhary, Nadia Tahiri Jouti, Meryam El Khachibi, Mouna Moutia, Imane Tabyaoui, Abdelhalim El Hou, Hafid Achtak, Sellama Nadifi, Norddine Habti, Abdallah Badou

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Extracellular Vesicles fromNanomaterials (Basel, Switzerland) · 2026
    Article
  2. Molecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Sedative and anxiolytic effects ofFrontiers in pharmacology · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Caper (Frontiers in pharmacology · 2022
    Review
  12. Article
  13. Article
  14. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Frontiers in plant science · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Khadija El AzharyEnvironnement and Health team, Polydisciplinary Faculty of Safi, Cadi Ayyad University, Safi, Morocco.
Nadia Tahiri JoutiLaboratory of Anatomical Pathology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Meryam El KhachibiCellular and Molecular Pathology Laboratory, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Mouna MoutiaLaboratory of Genetics and Cellular Enegineering, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Imane TabyaouiLaboratory of Anatomical Pathology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Abdelhalim El HouEnvironnement and Health team, Polydisciplinary Faculty of Safi, Cadi Ayyad University, Safi, Morocco.
Hafid AchtakEnvironnement and Health team, Polydisciplinary Faculty of Safi, Cadi Ayyad University, Safi, Morocco.
Sellama NadifiCellular and Molecular Pathology Laboratory, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Norddine HabtiLaboratory of Genetics and Cellular Enegineering, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Abdallah BadouEnvironnement and Health team, Polydisciplinary Faculty of Safi, Cadi Ayyad University, Safi, Morocco. abdallahbadou@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral chronic inflammatory diseases are characterized by inappropriate CD4+ T cell response. In the present study, we assessed the ability of Capparis spinosa L. (CS) preparation to orientate, in vivo, the immune response mediated by CD4+ T cells towards an anti-inflammatory response.

methodsThe in vivo study was carried out by using the contact hypersensitivity (CHS) model in Swiss mice. Then we performed a histological analysis followed by molecular study by using real time RT-PCR. We also realized a phytochemical screening and a liquid-liquid separation of CS preparation.

resultsOur study allowed us to detect a significantly reduced edema in mice treated with CS preparations relative to control. CS effect was dose dependent, statistically similar to that observed with indomethacin, independent of the plant genotype and of the period of treatment. Furthermore, our histology studies revealed that CS induced a significant decrease in immune cell infiltration, in vasodilatation and in dermis thickness in the inflammatory site. Interestingly, we showed that CS operated by inhibiting cytokine gene expression including IFNγ, IL-17 and IL-4. Besides, phytochemical screening of CS extract showed the presence of several chemical families such as saponins, flavonoids and alkaloids. One (hexane fraction) out of the three distinct prepared fractions, exhibited an anti-inflammatory effect similar to that of the raw preparation, and would likely contain the bioactive(s) molecule(s).

conclusionsAltogether, our data indicate that CS regulates inflammation induced in vivo in mice and thus could be a source of anti-inflammatory molecules, which could be used in some T lymphocyte-dependent inflammatory diseases.

Indexed as

AcetatesAnimalsAnti-Inflammatory Agents, Non-SteroidalCapparisCytokinesDermatitis, ContactDinitrofluorobenzeneFemaleGene ExpressionGenotypeHexanesInflammationMethanolMicePlant ExtractsAcetatesAnti-Inflammatory Agents, Non-SteroidalCytokinesDinitrofluorobenzeneethyl acetateHexanesMethanolPlant ExtractsAnti-inflammationCapparis spinosa LCD4+ T cellsImmunomodulationTh1Th2 and Th17

Identifiers

PMID28143472
PMCPMC5282892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.